The Justice Department is planning to focus more criminal enforcement on the pharmaceutical industry’s interaction with foreign officials, the head of the department’s Criminal Division warned on Thursday.

Assistant Attorney General Lanny Breuer, addressing the 10th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum, said the application of the Foreign Corrupt Practices Act to the pharmaceutical industry will be pushed “in the months and years ahead.” He noted the depth of government involvement in foreign health care systems and said it creates a “significant risk that corrupt payments will infect the process.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]